CCG-203971

• Description:

  CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  408.88

• Molecular Formula:

  C23H21ClN2O3

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  1443437-74-8